Overexpression of ZBTB10 in human ovarian cancer cell lines led to suppression of FSH-induced angiogenesis by downregulating VEGF, COX2 and survivin [baculoviral inhibitor of apoptosis repeat-containing 5 (BIRC5)] (Lai et al., 2013). This evidence concerns the gene BRD2 and ovarian cancer.